Market Exclusive

Eli Lilly and Company (NYSE:LLY) reported earnings of $1.11 per share beating Walls Streets expectations.

Eli Lilly and Company (NYSE:LLY) reported Q2 2017 earnings this Morning, coming in at $1.11 per share, beating Wall Street’s estimates of $1.05 per Share. Revenue for the quarter came in at $5.82 billion beating analyst estimates of $5.60 billion

Analyst Coverage For Eli Lilly and Company (NYSE:LLY)
These are 1 Sell Rating, 4 Hold Ratings, 11 Buy Ratings .
The current consensus rating for Eli Lilly and Company (NYSE:LLY) is Buy (Score: 2.63) with a consensus target price of $88.67 , a potential (4.63% upside)Recent Insider Trading for Eli Lilly and Company (NYSE:LLY)

Dividend History for Eli Lilly and Company (NYSE:LLY)

Recent Trading for Eli Lilly and Company (NYSE:LLY) Shares of Eli Lilly and Company closed the previous trading session at 81.88 down -2.86 -3.38% with 3,952,164 shares trading hands.

Exit mobile version